STOCK TITAN

[Form 4] USANA HEALTH SCIENCES INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

USANA Health Sciences (USNA) reported an insider stock acquisition by a director. On 10/23/2025, the director acquired 1,057 shares of common stock through the settlement of restricted stock units, coded M (derivative conversion).

The shares were delivered at a stated price of $0. Following the transaction, the director beneficially owns 7,986 shares directly, with 2,115 RSUs remaining outstanding. Each RSU represents the right to receive one share of USNA common stock. The RSUs vest in four 25% installments on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

USANA Health Sciences (USNA) ha riportato un'acquisizione azionaria interna da parte di un amministratore. Il 23/10/2025, il direttore ha acquisito 1.057 azioni ordinarie mediante la liquidazione di unità azionarie vincolate, codificate M (conversione derivativa).

Le azioni sono state consegnate a un prezzo dichiarato di 0$. A seguito dell'operazione, l'amministratore detiene direttamente 7.986 azioni, con 2.115 RSU rimaste in circolazione. Ogni RSU rappresenta il diritto a ricevere una azione delle azioni ordinarie USNA. Le RSU vanno a maturare in quattro tranche del 25% ciascuna il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó una adquisición de acciones por parte de un director. El 23/10/2025, el director adquirió 1.057 acciones ordinarias mediante la liquidación de unidades de acciones restringidas, codificadas M (conversión derivativa).

Las acciones fueron entregadas a un precio declarado de $0. Tras la operación, el director posee beneficiosamente 7.986 acciones directamente, con 2.115 RSU pendientes de vencimiento. Cada RSU representa el derecho a recibir una acción de las acciones ordinarias de USNA. Las RSU vencen en cuatro cuotas del 25% cada una el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사에 의한 내부자 주식 취득을 보고했습니다. 2025년 10월 23일, 이사는 1,057주 일반주M으로 표기된 제한 주식단위의 결제 를 통해 취득했습니다(파생 변환).

주식은 0달러의 명시 가격으로 인도되었습니다. 이번 거래 이후 이사는 직접적으로 7,986주를 보유하고 있으며 2,115 RSU가 남아 있습니다. 각 RSU는 USNA 일반주를 1주 받으실 권리를 나타냅니다. RSU는 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일의 네 차례에 걸쳐 25%씩 vest됩니다.

USANA Health Sciences (USNA) a rapporté une acquisition d'actions par un administrateur. Le 23/10/2025, l'administrateur a acquis 1 057 actions ordinaires par le règlement d'unités d'actions restreintes, codées M (conversion dérivée).

Les actions ont été livrées à un prix affiché de 0 $. Suite à la transaction, l'administrateur détient directement 7 986 actions, avec 2 115 RSU en cours d'échéance. Chaque RSU donne droit à recevoir une action ordinaire de USNA. Les RSU vestent en quatre tranches de 25 % chacune les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026.

USANA Health Sciences (USNA) meldete einen Insider-Kauf durch einen Direktor. Am 23.10.2025 erwarb der Direktor 1.057 Stammaktien durch die Abwicklung von Restricted-Stock-Unites, codiert M (Derivative Conversion).

Die Aktien wurden zu einem angegebenen Preis von 0 $ geliefert. Nach der Transaktion besitzt der Direktor direkt 7.986 Aktien, mit 2.115 RSU verbleibend. Jede RSU berechtigt zum Erhalt einer USNA-Stammaktie. Die RSU vesten in vier Raten von jeweils 25 % am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026.

USANA Health Sciences (USNA) أفادت بشراء داخلي للأسهم من قبل مدير. في 23/10/2025، قام المدير بشراء 1,057 سهمًا عاديًا من خلال تسوية وحدات الأسهم المقيدة، المشفرة M (تحويل مشتق).

تم تسليم الأسهم بسعر محدد قدره $0. عقب الصفقة، يمتلك المدير بشكل مفيد 7,986 سهمًا مباشرة، مع وجود 2,115 RSU لا تزال قائمة. تمثل كل RSU حق الحصول على سهم واحد من أسهم USNA العادية. تُقفل RSU على مدى أربع دفعات بنسبة 25% في التواريخ التالية: 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026.

Positive
  • None.
Negative
  • None.

USANA Health Sciences (USNA) ha riportato un'acquisizione azionaria interna da parte di un amministratore. Il 23/10/2025, il direttore ha acquisito 1.057 azioni ordinarie mediante la liquidazione di unità azionarie vincolate, codificate M (conversione derivativa).

Le azioni sono state consegnate a un prezzo dichiarato di 0$. A seguito dell'operazione, l'amministratore detiene direttamente 7.986 azioni, con 2.115 RSU rimaste in circolazione. Ogni RSU rappresenta il diritto a ricevere una azione delle azioni ordinarie USNA. Le RSU vanno a maturare in quattro tranche del 25% ciascuna il 24 luglio 2025, 23 ottobre 2025, 22 gennaio 2026 e 23 aprile 2026.

USANA Health Sciences (USNA) informó una adquisición de acciones por parte de un director. El 23/10/2025, el director adquirió 1.057 acciones ordinarias mediante la liquidación de unidades de acciones restringidas, codificadas M (conversión derivativa).

Las acciones fueron entregadas a un precio declarado de $0. Tras la operación, el director posee beneficiosamente 7.986 acciones directamente, con 2.115 RSU pendientes de vencimiento. Cada RSU representa el derecho a recibir una acción de las acciones ordinarias de USNA. Las RSU vencen en cuatro cuotas del 25% cada una el 24 de julio de 2025, 23 de octubre de 2025, 22 de enero de 2026 y 23 de abril de 2026.

USANA Health Sciences (USNA) 이사에 의한 내부자 주식 취득을 보고했습니다. 2025년 10월 23일, 이사는 1,057주 일반주M으로 표기된 제한 주식단위의 결제 를 통해 취득했습니다(파생 변환).

주식은 0달러의 명시 가격으로 인도되었습니다. 이번 거래 이후 이사는 직접적으로 7,986주를 보유하고 있으며 2,115 RSU가 남아 있습니다. 각 RSU는 USNA 일반주를 1주 받으실 권리를 나타냅니다. RSU는 2025년 7월 24일, 2025년 10월 23일, 2026년 1월 22일, 2026년 4월 23일의 네 차례에 걸쳐 25%씩 vest됩니다.

USANA Health Sciences (USNA) a rapporté une acquisition d'actions par un administrateur. Le 23/10/2025, l'administrateur a acquis 1 057 actions ordinaires par le règlement d'unités d'actions restreintes, codées M (conversion dérivée).

Les actions ont été livrées à un prix affiché de 0 $. Suite à la transaction, l'administrateur détient directement 7 986 actions, avec 2 115 RSU en cours d'échéance. Chaque RSU donne droit à recevoir une action ordinaire de USNA. Les RSU vestent en quatre tranches de 25 % chacune les 24 juillet 2025, 23 octobre 2025, 22 janvier 2026 et 23 avril 2026.

USANA Health Sciences (USNA) meldete einen Insider-Kauf durch einen Direktor. Am 23.10.2025 erwarb der Direktor 1.057 Stammaktien durch die Abwicklung von Restricted-Stock-Unites, codiert M (Derivative Conversion).

Die Aktien wurden zu einem angegebenen Preis von 0 $ geliefert. Nach der Transaktion besitzt der Direktor direkt 7.986 Aktien, mit 2.115 RSU verbleibend. Jede RSU berechtigt zum Erhalt einer USNA-Stammaktie. Die RSU vesten in vier Raten von jeweils 25 % am 24. Juli 2025, 23. Oktober 2025, 22. Januar 2026 und 23. April 2026.

USANA Health Sciences (USNA) أفادت بشراء داخلي للأسهم من قبل مدير. في 23/10/2025، قام المدير بشراء 1,057 سهمًا عاديًا من خلال تسوية وحدات الأسهم المقيدة، المشفرة M (تحويل مشتق).

تم تسليم الأسهم بسعر محدد قدره $0. عقب الصفقة، يمتلك المدير بشكل مفيد 7,986 سهمًا مباشرة، مع وجود 2,115 RSU لا تزال قائمة. تمثل كل RSU حق الحصول على سهم واحد من أسهم USNA العادية. تُقفل RSU على مدى أربع دفعات بنسبة 25% في التواريخ التالية: 24 يوليو 2025، 23 أكتوبر 2025، 22 يناير 2026، و23 أبريل 2026.

USANA Health Sciences (USNA) 报告了一名董事的内部人交易。于2025年10月23日,董事通过结算受限股票单位(RSU)以编码为 M 的衍生转换购买了 1,057 股普通股

这些股票以一个标注价格 $0 发出。交易完成后,该董事直接拥有 7,986 股,尚有 2,115 RSU 尚未到期。每个 RSU 代表获得一股 USNA 普通股的权利。RSU 将在四次中按每次 25% 的比例分期归属,日期分别为 2025 年 7 月 24 日2025 年 10 月 23 日2026 年 1 月 22 日2026 年 4 月 23 日

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Winssinger Frederic J

(Last) (First) (Middle)
2944 N 44TH STREET
SUITE 250

(Street)
PHOENIX AZ 85018

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
USANA HEALTH SCIENCES INC [ USNA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/23/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/23/2025 M 1,057 A (1) 7,986 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 10/23/2025 M 1,057 (2) (2) Common Stock 1,057 $0 2,115 D
Explanation of Responses:
1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
2. Restricted Stock Units vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
Remarks:
/s/ Joshua Foukas, Attorney-in-Fact 10/27/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did USNA's director report on Form 4 for 10/23/2025?

A director acquired 1,057 shares of USANA common stock via RSU settlement, reported with transaction code M.

How many USNA shares does the director own after the transaction?

Beneficial ownership is 7,986 shares directly following the reported transaction.

What derivative securities remain after the transaction for USNA?

The director holds 2,115 RSUs following the reported transaction.

What is the vesting schedule for the reported USNA RSUs?

RSUs vest 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.

What does transaction code M indicate in the USNA filing?

Code M indicates a conversion of a derivative security, here RSUs converting into common stock.

What was the price for the RSU conversion in the USNA Form 4?

The reported price for the RSU settlement was $0.
Usana Health Sciences Inc

NYSE:USNA

USNA Rankings

USNA Latest News

USNA Latest SEC Filings

USNA Stock Data

358.31M
10.40M
42.93%
61.22%
3.86%
Packaged Foods
Medicinal Chemicals & Botanical Products
Link
United States
SALT LAKE CITY